Site map
-
Guidelines
-
Whole blood and components
-
A to Z
- Accident
- Acid indigestion
- Acne
- Addiction and drug abuse
- Adrenal failure
- Age
- Air crew and air traffic controllers
- Allergy
- Alopecia
- Anaemia
- Anaesthetic
- Animal bite, non-human
- Anti-androgens
- Antibiotic therapy
- Anticoagulant therapy
- Arrhythmias
- Asthma
- Autoimmune disease
- Back problems
- Bleeding disorder
- Blood pressure, high
- Blood pressure, low
- Blood safety
- Body piercing
- Breastfeeding
- Cardiac surgery
- Cardiovascular disease (CVD)
- Catarrh
- Central nervous system (CNS) disease
- Cerebrovascular disease and intracranial haemorrhage
- Cervical dysplasia
- Chest pain
- Chiropody
- Chondromalacia
- Chronic fatigue syndrome (CFS)
- Clinical trials
- Clopidogrel
- Coeliac disease
- Communication difficulties
- Complementary therapy
- Conn's syndrome
- Contraceptive use
- Coronavirus infection
- Decompression illness
- Dental treatment
- Dermatitis
- Diabetes insipidus
- Diabetes mellitus
- Disabled donor
- Diuretics
- Diverticular disease
- Drug treatment
- Ehlers-Danlos syndrome (EDS)
- Endocarditis
- Endometriosis
- Endoscopy
- Epilepsy
- Erectile dysfunction
- Etretinate
- Exercise
- Eye disease
- Faints
- Familial pseudohyperkalaemia (FP)
- Fertility
- Fibromyalgia
- Frequency of donation
- Gall bladder disease
- Gastroenteritis
- Gastrointestinal disease
- Giardiasis
- Glycogen storage disease (GSD)
- Gout
- Growth hormone (GH)
- Guillain-Barré syndrome
- Haematological disease
- Haematuria
- Haemochromatosis
- Haemoglobin disorders
- Haemoglobin estimation
- Haemolytic anaemia
- Haemorrhoids
- Hair removal
- Hazardous activity
- Headache
- Healthcare worker
- Henna painting
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis E
- Hepatitis of unknown origin
- Herpes simplex
- Hormone replacement therapy (HRT)
- Human immunodeficiency virus (HIV)
- Human T-cell lymphotropic virus (HTLV)
- Huntington's disease
- Hydrocephalus
- Hypercholesterolaemia
- Hypnotics
- Immune thrombocytopenia
- Immunisation
- Immunisation, live
- Immunisation, non-live
- Immunodeficiency
- Immunoglobulin therapy
- Infection, acute
- Infection, chronic
- Infection, general
- Infectious diseases, contact with
- Inflammatory bowel disease (IBD)
- Inherited diseases
- Investigations
- Irritable bowel syndrome (IBS)
- Jaundice
- Kidney and bladder disease
- Klinefelter syndrome
- Laser treatment
- Liver disease
- Malaria
- Malaria - plasmapheresis donors
- Malignancy
- Marfan syndrome
- Ménière’s disease
- Menopause
- Mental health problems
- Migraine
- Monoclonal antibody therapy and other biological modalities
- Mpox
- Narcolepsy
- Neurobehavioural disorders
- Neurofibromatosis (NF)
- Neurosurgery
- Night sweats
- Non-consented exposure to human body fluids
- Non-contagious diseases, contact with
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Nose bleeds
- Oseltamivir
- Osteoarthritis
- Osteomyelitis
- Osteopenia
- Paget's disease of bone
- Painkillers
- Palpitations
- Parvovirus B19
- Peptic ulcer
- Periods
- Perthes disease
- Pituitary disorders
- Platelet count
- Platelet disorders
- Pneumothorax
- Polycystic ovary syndrome (PCOS)
- Polycythaemia and raised haemoglobin
- Porphyria
- Pre- and post-exposure prophylaxis (PrEP, PEP) for HIV prevention
- Pregnancy
- Prion-associated diseases
- Proctitis
- Prostate problems
- Psoriasis
- Pyrexia
- Rabies
- Radiation therapy
- Radionuclides
- Raynaud's syndrome
- Respiratory disease
- Rheumatic fever
- Sarcoidosis
- Sex worker
- Sexually transmitted disease (STD)
- Shunts, stents and devices
- Sickle cell trait
- Skin disease
- Sleep apnoea
- Smallpox immunisation
- Smoking
- Smoking cessation
- South American trypanosomiasis
- South American trypanosomiasis - plasmapheresis donors
- Spina bifida
- Splenectomy
- Steroid therapy
- Stoma
- Superficial thrombophlebitis
- Surgery
- Syphilis
- Tendonitis
- Tetanus
- Threadworms
- Thrombosis and thrombophilia
- Thrush
- Thyroid disease
- Tissue and organ recipients
- Topical medication
- Toxoplasmosis
- Transfusion
- Transgender and non-binary individuals
- Travel
- Tropical viruses
- Tropical viruses - plasmapheresis donors
- Tuberculin PPD test
- Tuberculosis (TB)
- Turner syndrome
- Urinary catheterisation
- Valproate and topiramate
- Varicose veins and chronic venous insufficiency
- Vertigo
- Viral haemorrhagic fever (VHF)
- Vitamins and other nutritional supplements
- Warts
- Weight
- Weight loss medication
- West Nile Virus (WNV)
- West Nile Virus (WNV) - plasmapheresis donors
- Wounds, mouth and skin ulcers
- Xenotransplantation
- Xenotropic murine leukemia virus-related virus (XMRV)
- Zanamivir
- Testosterone replacement therapy (TRT)
- Updates
- Source files
- Drugs and platelet donation
- Using these guidelines
- Appendix 1: Estimated blood volume for female donors
- Appendix 3: Maximum permitted extracorporeal volume (ECV) for component donors
- Appendix 4: Management of post donation illness
- Appendix 2: Immunisations
-
A to Z
-
Geographical Disease Risk Index
-
A to Z
- Afghanistan
- Aland (Åland) Islands
- Albania
- Algeria
- American Samoa
- Andorra
- Angola
- Anguilla
- Antarctica
- Antigua and Barbuda
- Argentina
- Armenia
- Aruba
- Australia
- Austria
- Azerbaijan
- Bahamas, The
- Bahrain
- Bangladesh
- Barbados
- Belarus
- Belgium
- Belize
- Benin
- Bermuda
- Bhutan
- Bolivia
- Bonaire, Sint Eustatius and Saba
- Bosnia and Herzegovina
- Botswana
- Bouvet Island
- Brazil
- British Indian Ocean Territory (BIOT)
- British Virgin Islands (BVI)
- Brunei Darussalam
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Cape Verde
- Cayman Islands
- Central African Republic (CAR)
- Chad
- Chile
- China
- Christmas Island
- Cocos (Keeling) Islands
- Colombia
- Comoros
- Congo, Democratic Republic of the (DRC)
- Congo, Republic of the
- Cook Islands
- Costa Rica
- Cote (Côte) d'Ivoire
- Croatia
- Cuba
- Curacao (Curaçao)
- Cyprus
- Czechia
- Denmark
- Djibouti
- Dominica
- Dominican Republic
- Timor Leste
- Ecuador
- Egypt
- El Salvador
- Equatorial Guinea
- Eritrea
- Estonia
- Eswatini
- Ethiopia
- Falkland Islands
- Faroe Islands
- Fiji
- Finland
- France
- French Guiana
- French Polynesia
- French Southern Territories and Antarctic Lands
- Gabon
- Gambia, The
- Georgia
- Germany
- Ghana
- Gibraltar
- Golan Heights
- Greece
- Greenland
- Grenada
- Guadeloupe
- Guam
- Guatemala
- Guernsey
- Guinea
- Guinea-Bissau
- Guyana
- Haiti
- Heard Island and McDonald Islands
- Honduras
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Isle of Man
- Israel
- Italy
- Jamaica
- Japan
- Jersey
- Jordan
- Kazakhstan
- Kenya
- Kiribati
- Kosovo
- Kuwait
- Kyrgyzstan
- Laos
- Latvia
- Lebanon
- Lesotho
- Liberia
- Libya
- Liechtenstein
- Lithuania
- Luxembourg
- Macao (Macau)
- Madagascar
- Malawi
- Malaysia
- Maldives
- Mali
- Malta
- Marshall Islands
- Martinique
- Mauritania
- Mauritius
- Mayotte
- Mexico
- Micronesia
- Moldova
- Monaco
- Mongolia
- Montenegro
- Montserrat
- Morocco
- Mozambique
- Myanmar
- Namibia
- Nauru
- Nepal
- Netherlands
- New Caledonia
- New Zealand
- Nicaragua
- Niger
- Nigeria
- Niue
- Norfolk Island
- North Korea
- North Macedonia
- Northern Mariana Islands
- Norway
- Oman
- Pakistan
- Palau
- Panama
- Papua New Guinea
- Paraguay
- Peru
- Philippines
- Pitcairn Islands
- Poland
- Portugal
- Puerto Rico
- Qatar
- Reunion (Réunion)
- Romania
- Russia
- Rwanda
- Saint Barthelemy
- Saint Helena, Ascension and Tristan da Cunha
- Saint Kitts and Nevis
- Saint Lucia
- Saint Martin
- Saint Pierre and Miquelon
- Saint Vincent and the Grenadines
- Samoa
- San Marino
- Sao Tome and Principe (São Tomé and Príncipe)
- Saudi Arabia
- Senegal
- Serbia
- Seychelles
- Sierra Leone
- Singapore
- Sint Maarten
- Slovakia
- Slovenia
- Solomon Islands
- Somalia
- South Africa
- South Georgia and the South Sandwich Islands
- South Korea
- South Sudan
- Spain
- Sri Lanka
- Sudan
- Suriname
- Svalbard and Jan Mayen
- Sweden
- Switzerland
- Syria
- Taiwan
- Tajikistan
- Tanzania
- Thailand
- Togo
- Tokelau
- Tonga
- Trinidad and Tobago
- Tunisia
- Turkey
- Turkmenistan
- Turks and Caicos Islands
- Tuvalu
- Uganda
- Ukraine
- United Arab Emirates (UAE)
- United Kingdom (UK)
- United States of America (USA)
- United States Minor Outlying Islands (USMOI)
- United States Virgin Islands (USVI)
- Uruguay
- Uzbekistan
- Vanuatu
- Vatican City
- Venezuela
- Vietnam
- Wallis and Futuna
- Palestine
- Western Sahara
- Yemen
- Zambia
- Zimbabwe
- Borneo
- Caribbean
- Polynesia
- West Indies
- Source files
- Updates
- Cross-references to relevant entries in the donor selection guidelines
- Using these guidelines
-
A to Z
-
Tissue (deceased donors)
-
A to Z
- Acanthamoeba (ocular infection)
- Accident
- Achondroplasia
- Addiction and drug abuse
- African trypanosomiasis
- Age
- Alcoholism
- Allergy
- Anaemia
- Animal bite, non-human
- Ankylosing spondylitis (AS)
- Anthrax
- Antibiotic therapy
- Arthritis
- Asthma
- Autoimmune disease
- Avascular necrosis of the femoral head (hip)
- Babesiosis
- Bacillus Calmette-Guérin (BCG)
- Basal cell carcinoma (BCC)
- Bleeding disorder
- Blind donor
- Blood pressure, high
- Body piercing
- Breast lump
- Breastfeeding
- Bronchitis
- Brucellosis
- Cardiac surgery
- Cardiomyopathy
- Cardiovascular disease (CVD)
- Catarrh
- Central nervous system (CNS) disease
- Cervical dysplasia
- Chickenpox
- Chondromalacia
- Chronic fatigue syndrome (CFS)
- Cirrhosis
- Clinical trials
- Coeliac disease
- Colostomy
- Communication difficulties
- Complementary therapy
- Congo fever
- Contact lenses
- Contraceptive implant
- Contraceptive injection
- Contraceptive pill
- Corneal transplant
- Coronary thrombosis
- Coronavirus infection
- Death from unknown causes
- Deep vein thrombosis (DVT)
- Dementia
- Dermatitis
- Diabetes insipidus
- Diabetes mellitus
- Diarrhoea
- Disabled donor
- Disease of unknown aetiology
- Diverticulosis
- Down's syndrome
- Drowning
- Drug treatment
- Edwards' syndrome
- Ehlers-Danlos syndrome (EDS)
- Electrolysis
- Emphysema
- Encephalitis
- Endocarditis
- Endometriosis
- Epilepsy
- Eye disease
- Eye drops
- Factor V Leiden
- Fertility
- Fibromyalgia
- Filariasis
- Gall bladder disease
- Giardiasis
- Gilbert's syndrome
- Glasses
- Glaucoma
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Gout
- Granuloma inguinale
- Growth hormone (GH)
- Guillain-Barré syndrome
- Haematological disease
- Haematuria
- Haemochromatosis
- Haemoglobin disorders
- Haemolytic anaemia
- Haemorrhoids
- Headache
- Heaf test
- Healthcare worker
- Henna painting
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis E
- Hepatitis of unknown origin
- Hereditary elliptocytosis
- Hereditary spherocytosis
- Herpes, genital
- Herpes, ocular
- Herpes, oral
- Herpes simplex
- Herpes zoster
- Hip dysplasia
- Hormone replacement and sex hormone therapy
- Human immunodeficiency virus (HIV)
- Human T-cell lymphotropic virus (HTLV)
- Huntington's disease
- Hydatid disease
- Hydrocephalus
- Hypnotics
- Ileostomy
- Immune thrombocytopenia
- Immunisation
- Immunisation, live
- Immunisation, non-live
- Immunoglobulin therapy
- Immunosuppression
- Infection, acute
- Infection, chronic
- Infection, general
- Infection, tropical
- Infectious diseases, contact with
- Inflammatory bowel disease (IBD)
- Inherited diseases
- Inoculation injury
- Irritable bowel syndrome (IBS)
- Jaundice
- Kidney disease
- Klinefelter syndrome
- Laser treatment
- Leishmaniasis
- Leukaemia
- Malaria
- Malaria - contact in the UK
- Malignancy
- Malignant hypertension
- Mantoux test
- Marfan syndrome
- Measles
- Ménière's disease
- Meningitis
- Menopause
- Mental health problems
- Methicillin resistant staphylococcus aureus (MRSA)
- Mitral valve prolapse
- Mpox
- Multiple sclerosis (MS)
- Mumps
- Muscular dystrophy
- Myasthenia gravis (MG)
- Myelodysplastic syndrome (MDS)
- Myeloproliferative syndrome
- Myocarditis
- Necrotising soft tissue infections
- Neurofibromatosis (NF)
- Neurosurgery
- Night sweats
- Non-specific urethritis (NSU)
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Ocular surgery
- Ocular tissue recipient
- Organ donor
- Organ recipient
- Osteoarthritis
- Osteogenesis imperfecta (OI)
- Osteomalacia
- Osteomyelitis
- Osteoporosis
- Ovarian cyst
- Paget's disease of bone
- Painkillers
- Peptic ulcer
- Perthes disease
- Pituitary extract, human
- Plasma dilution
- Platelet disorders
- Pleurisy
- Pneumothorax
- Poisoning
- Polycythaemia
- Porphyria
- Pre- and post-exposure prophylaxis (PrEP, PEP) for HIV prevention
- Pregnancy
- Prion-associated diseases
- Prisons
- Progressive multifocal leukoencephalopathy (PML)
- Psoriasis
- Pulmonary embolism (PE)
- Pyelonephritis
- Pyrexia
- Pyruvate kinase deficiency (PKD)
- Q fever
- Quinsy
- Rabies
- Radiation therapy
- Radionuclides
- Raynaud's syndrome
- Recipients of normal human immunoglobulin
- Renal colic
- Respiratory disease
- Retinitis pigmentosa (RP)
- Reye's syndrome
- Rheumatic fever
- Rheumatoid arthritis (RA)
- Ringworm
- Rubella
- Sarcoidosis
- Sex worker
- Sexually transmitted disease (STD)
- Shingles
- Sickle cell trait
- Sideroblastic anaemia
- Skin disease
- Smallpox immunisation
- South American trypanosomiasis
- South American trypanosomiasis, risk of
- Spina bifida
- Spinal surgery
- Splenectomy
- Steroid therapy
- Stroke
- Syphilis
- Systemic lupus erythematosus (SLE)
- Tamoxifen
- Tetanus immunisation
- Thalassaemia major
- Thalassaemia trait
- Tropical viruses
- Therapeutic venesection
- Threadworms
- Thrombocytosis
- Thrombosis
- Thrush, oral
- Thrush, vaginal
- Thyroid disease
- Tissue and cell allograft recipients
- Tissues safety
- Toxoplasmosis
- Transfusion
- Transgender and non-binary individuals
- Travel
- Trypanosoma cruzi infection
- Tuberculosis (TB)
- Turner syndrome
- Vasculitis
- Viral haemorrhagic fever (VHF)
- Vitamin treatment
- Warts
- Warts, genital
- West Nile Virus (WNV)
- Whooping cough
- Wilson's disease
- Xenotransplantation
- Xenotropic murine leukemia virus-related virus (XMRV)
- Yaws
- Updates
- Source files
- Appendix 1: Medical criteria for the withdrawal of donations following information received after donation
- Appendix 2: Calculation of blood and plasma dilution
- Appendix 4: Grading of selected central nervous system tumours (WHO 2016 classification)
- Using these guidelines
- Appendix 3: Immunisations
-
A to Z
-
Tissue (live donors)
-
A to Z
- Achondroplasia
- Addiction and drug abuse
- African trypanosomiasis
- Age
- Alcoholism
- Allergy
- Anaemia
- Animal bite, non-human
- Ankylosing spondylitis (AS)
- Anthrax
- Antibiotic therapy
- Arthritis
- Asthma
- Autoimmune disease
- Avascular necrosis of the femoral head (hip)
- Babesiosis
- Bacillus Calmette-Guérin (BCG)
- Basal cell carcinoma (BCC)
- Bleeding disorder
- Blood pressure, high
- Body piercing
- Breast lump
- Bronchitis
- Brucellosis
- Cardiac surgery
- Cardiomyopathy
- Cardiovascular disease (CVD)
- Catarrh
- Central nervous system (CNS) disease
- Cervical dysplasia
- Chickenpox
- Chondromalacia
- Chronic fatigue syndrome (CFS)
- Cirrhosis
- Clinical trials
- Coeliac disease
- Colostomy
- Communication difficulties
- Complementary therapy
- Congo fever
- Contraceptive implant
- Contraceptive injection
- Contraceptive pill
- Corneal transplant
- Coronary thrombosis
- Coronavirus infection
- Deep vein thrombosis (DVT)
- Dementia
- Dermatitis
- Diabetes insipidus
- Diabetes mellitus
- Diarrhoea
- Disabled donor
- Disease of unknown aetiology
- Diverticulosis
- Drug treatment
- Ehlers-Danlos syndrome (EDS)
- Electrolysis
- Emphysema
- Endocarditis
- Endometriosis
- Epilepsy
- Eye disease
- Eye drops
- Factor V Leiden
- Fertility
- Fibromyalgia
- Filariasis
- Gall bladder disease
- Giardiasis
- Gilbert's syndrome
- Glaucoma
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Gout
- Granuloma inguinale
- Growth hormone (GH)
- Guillain-Barré syndrome
- Haematological disease
- Haematuria
- Haemochromatosis
- Haemoglobin disorders
- Haemolytic anaemia
- Haemorrhoids
- Headache
- Heaf test
- Healthcare worker
- Henna painting
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis E
- Hepatitis of unknown origin
- Hereditary elliptocytosis
- Hereditary spherocytosis
- Herpes, genital
- Herpes, oral
- Herpes simplex
- Herpes zoster
- Hip dysplasia
- Hormone replacement and sex hormone therapy
- Human immunodeficiency virus (HIV)
- Human T-cell lymphotropic virus (HTLV)
- Huntington's disease
- Hydatid disease
- Hydrocephalus
- Hypnotics
- Ileostomy
- Immune thrombocytopenia
- Immunisation
- Immunisation, live
- Immunisation, non-live
- Immunoglobulin therapy
- Immunosuppression
- Infection, acute
- Infection, chronic
- Infection, general
- Infection, tropical
- Infectious diseases, contact with
- Inflammatory bowel disease (IBD)
- Inherited diseases
- Inoculation injury
- Irritable bowel syndrome (IBS)
- Jaundice
- Kidney disease
- Klinefelter syndrome
- Laser treatment
- Leishmaniasis
- Leukaemia
- Malaria
- Malaria - contact in the UK
- Malignancy
- Malignant hypertension
- Mantoux test
- Marfan syndrome
- Measles
- Ménière's disease
- Meningitis
- Menopause
- Mental health problems
- Methicillin resistant staphylococcus aureus (MRSA)
- Mitral valve prolapse
- Mpox
- Multiple sclerosis (MS)
- Mumps
- Muscular dystrophy
- Myasthenia gravis (MG)
- Myelodysplastic syndrome (MDS)
- Myeloproliferative syndrome
- Myocarditis
- Neurofibromatosis (NF)
- Neurosurgery
- Night sweats
- Non-specific urethritis (NSU)
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Ocular surgery
- Ocular tissue recipient
- Organ donor
- Organ recipient
- Osteoarthritis
- Osteogenesis imperfecta (OI)
- Osteomalacia
- Osteomyelitis
- Osteoporosis
- Ovarian cyst
- Paget's disease of bone
- Painkillers
- Peptic ulcer
- Perthes disease
- Pituitary extract, human
- Platelet disorders
- Pleurisy
- Poisoning
- Polycythaemia
- Porphyria
- Pre- and post-exposure prophylaxis (PrEP, PEP) for HIV prevention
- Pregnancy
- Prion-associated diseases
- Psoriasis
- Pulmonary embolism (PE)
- Pyrexia
- Pyruvate kinase deficiency (PKD)
- Q fever
- Rabies
- Radiation therapy
- Radionuclides
- Raynaud's syndrome
- Recipients of normal human immunoglobulin
- Reiter's syndrome
- Renal colic
- Respiratory disease
- Retinitis pigmentosa (RP)
- Rheumatic fever
- Rheumatoid arthritis (RA)
- Ringworm
- Rubella
- Sarcoidosis
- Sex worker
- Sexually transmitted disease (STD)
- Shingles
- Sickle cell trait
- Skin disease
- Smallpox immunisation
- Snake bite
- South American trypanosomiasis
- South American trypanosomiasis, risk of
- Spina bifida
- Spinal surgery
- Splenectomy
- Steroid therapy
- Stroke
- Syphilis
- Systemic lupus erythematosus (SLE)
- Tamoxifen
- Tetanus immunisation
- Thalassaemia major
- Thalassaemia trait
- Therapeutic venesection
- Threadworms
- Thrombocytosis
- Thrombosis
- Thrush, oral
- Thrush, vaginal
- Thyroid disease
- Tissue and cell allograft recipients
- Tissues safety
- Toxoplasmosis
- Transfusion
- Transgender and non-binary individuals
- Travel
- Tropical viruses
- Trypanosoma cruzi infection
- Tuberculosis (TB)
- Turner syndrome
- Vasculitis
- Viral haemorrhagic fever (VHF)
- Vitamin treatment
- Warts
- Warts, genital
- West Nile Virus (WNV)
- Whooping cough
- Wilson's disease
- Xenotransplantation
- Xenotropic murine leukemia virus-related virus (XMRV)
- Yaws
- Updates
- Source files
- Appendix 1: Medical criteria for the withdrawal of donations following information received after donation
- Using these guidelines
- Appendix 2: Immunisations
-
A to Z
-
Bone marrow and peripheral blood stem cells
-
A to Z
- Accident
- Acetylcholinesterase (AChE) deficiency
- Addiction and drug abuse
- Adrenal failure
- African trypanosomiasis
- Age
- Allergy
- Anaemia
- Anaesthetic
- Angina pectoris
- Animal bite, non-human
- Ankylosing spondylitis (AS)
- Anthrax
- Antibiotic therapy
- Anticoagulant therapy
- Anticonvulsant therapy
- Antihistamine tablets
- Arrhythmias
- Arthritis
- Asthma
- Autoimmune disease
- Babesiosis
- Bacillus Calmette-Guérin (BCG)
- Back problems
- Basal cell carcinoma (BCC)
- Beta blockers
- Bleeding disorder
- Blood pressure, high
- Blood pressure, low
- Blood volume estimation
- Body piercing
- Breast lump
- Bronchitis
- Brucellosis
- Cardiac surgery
- Cardiomyopathy
- Cardiovascular disease (CVD)
- Catarrh
- Central nervous system (CNS) disease
- Cerebrovascular disease
- Cervical dysplasia
- Chickenpox
- Chiropody
- Chondromalacia
- Clinical trials
- Clopidogrel
- Coeliac disease
- Colostomy
- Communication difficulties
- Complementary therapy
- Congo fever
- Contraceptive implant
- Contraceptive injection
- Contraceptive pill
- Corneal transplant
- Coronary thrombosis
- Coronavirus infection
- Coronavirus vaccination
- Dementia
- Dental treatment
- Dermatitis
- Diabetes insipidus
- Diabetes mellitus
- Diarrhoea
- Digoxin
- Dilatation and curettage
- Disabled donor
- Disease of unknown aetiology
- Diuretics
- Diverticulosis
- Drug treatment
- Electrolysis
- Emphysema
- Endocarditis
- Endometriosis
- Epilepsy
- Eye disease
- Eye drops
- Faints
- Fertility
- Filariasis
- Gall bladder disease
- Granulocyte colony-stimulating factor (G-CSF)
- Giardiasis
- Glaucoma
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Glycogen storage disease (GSD)
- Gout
- Granuloma inguinale
- Growth hormone (GH)
- Guillain-Barré syndrome
- Haematological disease
- Haematuria
- Haemochromatosis
- Haemoglobin disorders
- Haemolytic anaemia
- Haemorrhoids
- Hazardous activity
- Headache
- Heaf test
- Healthcare worker
- Henna painting
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis E
- Hepatitis of unknown origin
- Hereditary elliptocytosis
- Hereditary spherocytosis
- Herpes, genital
- Herpes, oral
- Herpes simplex
- Herpes zoster
- Hormone replacement therapy (HRT)
- Human immunodeficiency virus (HIV)
- Human T-cell lymphotropic virus (HTLV)
- Huntington's disease
- Hydatid disease
- Hydrocephalus
- Hypercholesterolaemia
- Hypnotics
- Ileostomy
- Immune thrombocytopenia
- Immunisation
- Immunisation, live
- Immunisation, non-live
- Immunoglobulin A (IgA) deficiency
- Immunoglobulin therapy
- Immunosuppression
- Infection, acute
- Infection, chronic
- Infection, general
- Infection, tropical
- Infectious diseases, contact with
- Inflammatory bowel disease (IBD)
- Inherited diseases
- Inoculation injury
- Intermittent claudication
- Irritable bowel syndrome (IBS)
- Jaundice
- Kidney disease
- Klinefelter syndrome
- Laser treatment
- Leishmaniasis
- Leukaemia
- Liver disease
- Malaria
- Malaria - contact in the UK
- Malignancy
- Mantoux test
- Marfan syndrome
- Measles
- Ménière's disease
- Meningitis
- Menopause
- Mental health problems
- Methicillin resistant staphylococcus aureus (MRSA)
- Migraine
- Mpox
- Multiple sclerosis
- Mumps
- Muscular dystrophy
- Myasthenia gravis (MG)
- Myelodysplastic syndrome (MDS)
- Myeloproliferative syndrome
- Myocarditis
- Narcolepsy
- Neurofibromatosis (NF)
- Neurosurgery
- Night sweats
- Non-specific urethritis (NSU)
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Ocular surgery
- Ocular tissue recipient
- Operations
- Organ donor
- Organ recipient
- Osteoarthritis
- Osteomalacia
- Osteomyelitis
- Osteoporosis
- Ovarian cyst
- Paget's disease of bone
- Painkillers
- Peptic ulcer
- Periods
- Perthes disease
- Phlebitis
- Pituitary extract, human
- Platelet disorders
- Pleurisy
- Pneumothorax
- Poisoning
- Polycystic kidney disease
- Polycythaemia
- Porphyria
- Post-viral fatigue syndrome
- Pre- and post-exposure prophylaxis (PrEP, PEP) for HIV prevention
- Pregnancy
- Prion-associated diseases
- Psoriasis
- Pyrexia
- Pyruvate kinase deficiency (PKD)
- Q fever
- Rabies
- Radiation therapy
- Radionuclides
- Raynaud's syndrome
- Recipients of normal human immunoglobulin
- Reiter's syndrome
- Renal colic
- Respiratory disease
- Retinitis pigmentosa (RP)
- Rheumatic fever
- Rheumatoid arthritis (RA)
- Ringworm
- Rubella
- Sarcoidosis
- Self-catheterisation
- Sex worker
- Sexually transmitted disease (STD)
- Shingles
- Sickle cell trait
- Skin disease
- Smallpox immunisation
- Smoking cessation
- Snake bite
- South American trypanosomiasis
- South American trypanosomiasis, risk of
- Spina bifida
- Spinal surgery
- Splenectomy
- Steroid therapy
- Stroke
- Surgery
- Syphilis
- Systemic lupus erythematosus (SLE)
- Tamoxifen
- Tetanus immunisation
- Thalassaemia major
- Therapeutic venesection
- Threadworms
- Thrombosis and thrombophilia
- Thrush, oral
- Thrush, vaginal
- Thyroid disease
- Tissue and cell allograft recipients
- Tissues safety
- Topical medication
- Toxoplasmosis
- Transfusion
- Transgender individuals
- Transient ischaemic attack (TIA)
- Travel
- Tropical viruses
- Trypanosoma cruzi infection
- Tuberculosis (TB)
- Turner syndrome
- Varicose veins
- Vasculitis
- Viral haemorrhagic fever (VHF)
- Vitamin treatment
- Warts
- Warts, genital
- Weight
- West Nile Virus (WNV)
- Whooping cough
- Xenotransplantation
- Xenotropic murine leukemia virus-related virus (XMRV)
- Yaws
- Source files
- Updates
- Appendix 1: Medical criteria for the withdrawal of donations following information received after donation
- Using these guidelines
- Appendix 2: Immunisations
-
A to Z
-
Cord blood
-
A to Z
- Accident
- Addiction and drug abuse
- African trypanosomiasis
- Age
- Allergy
- Anaemia
- Animal bite, non-human
- Ankylosing spondylitis (AS)
- Anthrax
- Antibiotic therapy
- Arthritis
- Asthma
- Autoimmune disease
- Babesiosis
- Basal cell carcinoma (BCC)
- Bacillus Calmette-Guérin (BCG)
- Bleeding disorder
- Blood pressure, high
- Body piercing
- Breast lump
- Bronchitis
- Brucellosis
- Cardiac surgery
- Cardiomyopathy
- Cardiovascular disease (CVD)
- Catarrh
- Central nervous system (CNS) disease
- Cervical dysplasia
- Chickenpox
- Chiropody
- Chondromalacia
- Cirrhosis
- Clinical trials
- Coeliac disease
- Colostomy
- Communication difficulties
- Complementary therapy
- Congo fever
- Corneal transplant
- Coronary thrombosis
- Coronavirus infection
- Deep vein thrombosis (DVT)
- Dementia
- Dental treatment
- Dermatitis
- Diabetes insipidus
- Diabetes mellitus
- Diarrhoea
- Dilatation and curettage
- Disabled mother
- Disease of unknown aetiology
- Diverticulosis
- Drug treatment
- Electrolysis
- Emphysema
- Endocarditis
- Endometriosis
- Epilepsy
- Eye disease
- Eye drops
- Factor V Leiden
- Fertility
- Filariasis
- Food allergy
- Gall bladder disease
- Giardiasis
- Gilbert's syndrome
- Glaucoma
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Glycogen storage disease (GSD)
- Gout
- Granuloma inguinale
- Growth hormone (GH)
- Guillain-Barré syndrome
- Haematological disease
- Haematuria
- Haemochromatosis
- Haemoglobin disorders
- Haemolytic anaemia
- Haemorrhoids
- Headache
- Heaf test
- Healthcare worker
- Henna painting
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis E
- Hepatitis of unknown origin
- Hereditary elliptocytosis
- Hereditary spherocytosis
- Herpes, genital
- Herpes, oral
- Herpes simplex
- Herpes zoster
- Hormone replacement therapy (HRT)
- Human immunodeficiency virus (HIV)
- Human T-cell lymphotropic virus (HTLV)
- Huntington's disease
- Hydatid disease
- Hydrocephalus
- Hypnotics
- Ileostomy
- Immune thrombocytopenia
- Immunisation
- Immunisation, live
- Immunisation, non-live
- Immunoglobulin therapy
- Immunosuppression
- Infection, acute
- Infection, chronic
- Infection, general
- Infection, tropical
- Infectious diseases, contact with
- Inflammatory bowel disease (IBD)
- Inherited diseases
- Inoculation injury
- Irritable bowel syndrome (IBS)
- Jaundice
- Kidney disease
- Laser treatment
- Leishmaniasis
- Leukaemia
- Malaria
- Malaria - contact in the UK
- Malignancy
- Mantoux test
- Marfan syndrome
- Measles
- Ménière's disease
- Meningitis
- Mental health problems
- Methicillin resistant staphylococcus aureus (MRSA)
- Mitral valve prolapse
- Mpox
- Multiple sclerosis (MS)
- Mumps
- Muscular dystrophy
- Myasthenia gravis (MG)
- Myelodysplastic syndrome (MDS)
- Myeloproliferative syndrome
- Myocarditis
- Neurofibromatosis (NF)
- Neurosurgery
- Night sweats
- Non-specific urethritis (NSU)
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Ocular surgery
- Ocular tissue recipient
- Operations
- Organ donor
- Organ recipient
- Osteoarthritis
- Osteomalacia
- Osteomyelitis
- Osteoporosis
- Ovarian cyst
- Paget's disease of bone
- Painkillers
- Peptic ulcer
- Perthes disease
- Pituitary extract, human
- Platelet disorders
- Pleurisy
- Pneumothorax
- Poisoning
- Polycythaemia
- Porphyria
- Post-viral fatigue syndrome
- Pre- and post-exposure prophylaxis (PrEP, PEP) for HIV prevention
- Pregnancy
- Prion-associated diseases
- Psoriasis
- Pulmonary embolism (PE)
- Pyrexia
- Pyruvate kinase deficiency (PKD)
- Q fever
- Rabies
- Radiation therapy
- Radionuclides
- Raynaud's syndrome
- Recipients of normal human immunoglobulin
- Renal colic
- Respiratory disease
- Retinitis pigmentosa (RP)
- Rheumatic fever
- Rheumatoid arthritis (RA)
- Ringworm
- Rubella
- Sarcoidosis
- Self-catheterisation
- Sex worker
- Sexually transmitted disease (STD)
- Shingles
- Sickle cell trait
- Skin disease
- Smallpox immunisation
- Snake bite
- South American trypanosomiasis
- South American trypanosomiasis, risk of
- Spina bifida
- Spinal surgery
- Splenectomy
- Steroid therapy
- Stroke
- Surgery
- Syphilis
- Systemic lupus erythematosus (SLE)
- Tamoxifen
- Tetanus immunisation
- Therapeutic venesection
- Threadworms
- Thrombocytosis
- Thrombosis
- Thrush, oral
- Thrush, vaginal
- Thyroid disease
- Tissue and cell allograft recipients
- Tissues safety
- Toxoplasmosis
- Transfusion
- Travel
- Tropical viruses
- Trypanosoma cruzi infection
- Tuberculosis (TB)
- Turner syndrome
- Vasculitis
- Viral haemorrhagic fever (VHF)
- Vitamin treatment
- Warts
- Warts, genital
- West Nile Virus (WNV)
- Whooping cough
- Wilson's disease
- Xenotransplantation
- Xenotropic murine leukemia virus-related virus (XMRV)
- Yaws
- Source files
- Updates
- Appendix 1: Medical criteria for the withdrawal of donations following information received after donation
- Using these guidelines
- Appendix 2: Immunisations
-
A to Z
-
Red Book
-
Chapters
- Introduction
- Quality in blood and tissue establishments and hospital blood banks
-
Care and selection of whole blood and component donors (including donors of pre-deposit autologous blood)
- Introduction
- General principles
- Assessment of fitness to donate
- Informed consent
- Donor age
- Frequency of donation
- Volume of donation
- Medical history of donors
- Genetically determined conditions
- Donors on treatment with medications (drugs)
- Transfusion-transmissible infectious disease
- Travel history
- Prion-associated diseases
- Physical examination of donors
- Blood tests
- Autologous donation
- Premises and quality assurance at blood donor sessions
-
Collection of a blood or component donation
- Information to be provided to prospective donors of blood or blood components
- Information to be obtained from donors by Blood Establishments at every donation
- Haemoglobin screening
- Preparation of the venepuncture site
- Preparation of the blood pack
- Performance of the venepuncture
- Whole blood donation
- Component donation by apheresis
- Information to be provided to the donor post-donation
- Donor adverse events
- Adverse events
- Donor compensation
-
Evaluation and manufacture of blood components
- Scope of the guidelines
- Setting and maintaining specifications
- Component and process monitoring tests
- Component processing
- Component shelf life
- Labelling
- Component storage
- Non-conforming components and biohazards
- Component release
- Release of components which do not conform to specified requirements
- Transportation of blood components
- Component recall and traceability
-
Specifications for blood components
- Introduction
- Whole blood components
- Red cell components
- Platelet components
-
Plasma components
- 7.5.1: Fresh Frozen Plasma, Leucocyte Depleted
- 7.5.2: Fresh Frozen Plasma, Pathogen Reduced, Leucocyte Depleted
- 7.5.3: Cryoprecipitate, Leucocyte Depleted
- 7.5.4: Cryoprecipitate, Pooled, Leucocyte Depleted
- 7.5.5: Cryoprecipitate, Pooled, Pathogen Reduced, Leucocyte Depleted
- 7.5.6: Human Plasma for Fractionation, Leucocyte Depleted
- 7.5.7: Human Plasma for Fractionation, Cryoprecipitate Depleted, Leucocyte Depleted
- Granulocyte components
-
Components suitable for use in intrauterine transfusion, neonates and infants under 1 year
- 7.7.1: Red Cells for Intrauterine Transfusion, Leucocyte Depleted
- 7.7.2: Whole Blood for Exchange Transfusion, Leucocyte Depleted
- 7.7.3: Red Cells for Exchange Transfusion, Leucocyte Depleted
- 7.7.4: Red Cells for Neonates and Infants, Leucocyte Depleted
- 7.7.5: Red Cells in Additive Solution for Neonates and Infants, Leucocyte Depleted
- 7.7.6: Platelets for Intrauterine Transfusion, Leucocyte Depleted
- 7.7.7: Platelets for Neonatal Use, Leucocyte Depleted
- 7.7.8: Platelets in Plasma and Additive Solution for Neonatal Use, Leucocyte Depleted
- 7.7.9: Fresh Frozen Plasma for Neonates and Infants, Leucocyte Depleted
- 7.7.10: Fresh Frozen Plasma for Neonates and Infants, Pathogen Reduced, Leucocyte Depleted
- 7.7.11: Cryoprecipitate for Neonates and Infants, Leucocyte Depleted
- 7.7.12: Cryoprecipitate for Neonates and Infants, Pathogen Reduced, Leucocyte Depleted
-
Evaluation of novel blood components, production processes and blood packs – generic protocols
- Aims and introduction
- Evaluation of new red cell components for transfusion
- Evaluation of new platelet components for transfusion
- Evaluation of new fresh frozen plasma/cryoprecipitate components for transfusion
- Evaluation of plasma for fractionation for the manufacture of immunoglobulin
- Generic protocol for the evaluation of apheresis equipment
- Generic protocol for the evaluation of blood packs for whole blood donations and apheresis collections
- Further guidance on the evaluation of blood packs and apheresis collection systems containing new plasticisers and additive solutions, where they are combined
-
Microbiology tests for donors and donations – general specifications for laboratory test procedures
- General requirements
- Microbiology screening
- Specific screening targets
- Reinstatement of blood donors
- Recommended standards for the reduction of bacterial contamination of blood components
- Recommended standards for microbiological screening
- Recommended standards for environmental monitoring of processing facilities
- Investigation of suspected bacterial contamination of blood components
- Investigation of suspected transfusion-transmitted infection
- Reagent manufacture
-
Donation testing (red cell immunohaematology)
- Scope
- General requirements
- Samples
- Reagents and test kits
- Equipment
- Test procedure
- Reporting of results
- Release of tested components
- Laboratory test categories
- Mandatory testing of blood donations
- Additional testing
- Donations found to have a positive direct antiglobulin test
- Automated testing
- Manual testing
- Patient testing (red cell immunohaematology)
- Guidelines for the use of DNA/PCR techniques in Blood Establishments
- Molecular typing for red cell antigens
- HLA typing and HLA serology
- Granulocyte immunology
- Platelet immunology
- Tissue banking: general principles
- Tissue banking: selection of donors
-
Tissue banking: tissue retrieval and processing
- General considerations
- Retrieval
- Transportation conditions from retrieval site to Tissue Establishment
- Bacteriostasis and disinfection
- General guidelines for tissue processing
- Tissue storage
- Tracking of tissues
- Notification of serious adverse events and reactions
- Additional guidelines for skeletal tissue retrieval and processing
- Cardiovascular tissue retrieval and processing
- Skin retrieval and processing
- Ocular tissue retrieval, processing and storage
-
Haemopoietic progenitor cells
- Introduction
- Terminology
- Policy and procedure requirements and safety
- Adverse events and reactions
- Donor selection, consent and testing
- Collection, processing and storage
- Testing of haemopoietic progenitor cell donors and components
- Requirements for the timing of testing
- Labelling, packaging, transportation and release
- Disposal of haemopoietic progenitor cells
- Record maintenance
- Specification for the uniform labelling of blood, blood components and blood donor samples
- Specification for the uniform labelling of human tissue products using ISBT 128
-
Standards for electronic data interchange within the UK Blood Transfusion Services
- Introduction
- Control of message structures
- General protocol
- Envelope definition
- Message protocols
- Protocol 000001 - blood component dispatch information
- Protocol 000002 - blood derivative dispatch information
- Protocol 000003 - reagent dispatch information
- Protocol 000004 - blood component dispatch acknowledgement
- Protocol 000005 - blood component fate information
- Specification for blood pack base labels
- Specification for labelling consumables used in therapeutic product production
- About the Red Book
- Updates
- Annex 1: NIBSC standards available from MHRA South Mimms Laboratories
- Annex 2: ISBT 128 check character calculation
-
Annex 3: Provisional components
- A3.1: Platelets in Additive Solution and Plasma, Leucocyte Depleted, Pathogen-reduced
- A3.2: Red Cells in Additive Solution, Leucocyte Depleted, Pathogen Reduced
- A3.4: Red Cells, Rejuvenated and Washed, Leucocyte Depleted
- A3.3: Liquid Plasma, Leucocyte Depleted
- A3.6: Whole Blood, Leucocyte Depleted, for Clinical Studies
- A3.12: Platelets, Apheresis, in Additive Solution and Plasma, Leucocyte Depleted
- A3.9: Cryoprecipitate, Pooled, Leucocyte Depleted, Extended Shelf-life Post-thaw
- A3.10: Convalescent Plasma (VCOV-19), FFP, Leucocyte Depleted
- A3.11: Dried Plasma, Leucocyte Depleted
- A3.5: Red Cells for Neonates and Infants, Leucocyte Depleted, Washed
-
Annex 4: Redundant components
- A4.1: Granulocytes, Apheresis
- A4.2: Convalescent Plasma (COVID-19), FFP, Leucocyte Depleted
- A4.6: Whole Blood, Leucocyte Depleted
- A4.3: Convalescent Plasma (COVID-19), FFP, for Neonates and Infants, Leucocyte Depleted
- A4.4: Cryoprecipitate, Methylene Blue Treated and Removed, Leucocyte Depleted
- A4.5: Plasma, Cryoprecipitate Depleted, Leucocyte Depleted
- Annex 5: Contingency components
- Annex 6: Advanced therapy medicinal products
- Annex 7: Requirements for the timing of testing for hematopoietic progenitor cells – minimum standards and good practice
-
Chapters
- Updates
-
Whole blood and components
- Accessibility
- Contact
- Cookies
- Privacy
-
Transfusion practice
-
Consent for blood transfusion
- Transfusion information for patients
-
Guidance for healthcare practitioners
- Wrong blood/wrong patient
- Febrile non-haemolytic reaction
- Allergic and hypotensive reactions
- Transfusion-Associated Circulatory Overload (TACO)
- Non-TACO: Transfusion-Related Acute Lung Injury (TRALI)
- Haemolytic Transfusion Reaction (HTR)
- Transfusion-Transmitted Infection (TTI)
- Antibody formation
- Iron overload
- Other complications
- Training for consent for transfusion
- Infected Blood Inquiry
- Unknown risks
- Blood transfusion e-learning
- Clinical decision-making and authorising blood component transfusion
- UK Cell Salvage Action Group
- Transfusion committees in the UK
-
Consent for blood transfusion
- About JPAC
- Resources and documents
- Conditions of use